Hirono Nishiyama Selected Research

Rhinosinusitis

10/2020	Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients.
1/2020	Increased Serum Periostin Levels and Eosinophils in Nasal Polyps Are Associated with the Preventive Effect of Endoscopic Sinus Surgery for Asthma Exacerbations in Chronic Rhinosinusitis Patients.
1/2020	A novel pathophysiologic link between upper and lower airways in patients with chronic rhinosinusitis: Association of sputum periostin levels with upper airway inflammation and olfactory function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirono Nishiyama Research Topics

Disease

17	Asthma (Bronchial Asthma) 03/2024 - 01/2020
9	Cough 03/2024 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Rhinosinusitis 10/2020 - 01/2020
2	Hypersensitivity (Allergy) 01/2023 - 01/2023
2	Nasal Polyps (Nasal Polyp) 01/2020 - 01/2020
1	Airway Remodeling 03/2024
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2023
1	Gastroesophageal Reflux (GERD) 04/2023
1	Chronic Cough 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2023
1	Eosinophilia 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 11/2021
1	Retinal Artery Occlusion 11/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2020
1	Infections 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2020

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2020
8	Capsaicin (Zostrix)FDA Link 04/2023 - 01/2020
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2023 - 01/2022
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 11/2021
3	PeriostinIBA 01/2022 - 01/2020
2	InterleukinsIBA 03/2024 - 11/2021
2	AllergensIBA 01/2023 - 10/2020
1	dupilumabIBA 03/2024
1	Interleukin-13IBA 03/2024
1	OxidesIBA 01/2023
1	Theophylline (Theon)FDA LinkGeneric 01/2023
1	Tiotropium Bromide (Spiriva)FDA Link 01/2023
1	Omalizumab (Xolair)FDA Link 01/2023
1	mepolizumabIBA 01/2023
1	ORALIT (ORS)IBA 01/2023
1	Antitussive Agents (Antitussives)FDA Link 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Interleukin-5 (Interleukin 5)IBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	AnticoagulantsIBA 11/2021
1	Monoclonal AntibodiesIBA 11/2021
1	Enterotoxins (Enterotoxin)IBA 10/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 10/2020
1	SuspensionsIBA 10/2020
1	Procaterol (Pro-Air)IBA 10/2020
1	Docetaxel (Taxotere)FDA Link 09/2020

Therapy/Procedure

4	Bronchial Thermoplasty 04/2023 - 04/2022
2	Therapeutics 01/2023 - 01/2022
1	Nebulizers and Vaporizers (Inhaler) 01/2022
1	Aftercare (After-Treatment) 11/2021
1	Length of Stay 10/2020
1	Drug Therapy (Chemotherapy) 09/2020